Gruskin Daniel 4
4 · LogicBio Therapeutics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Gruskin Daniel
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-01+140,000→ 140,000 totalExercise: $0.70Exp: 2032-03-01→ Common Stock (140,000 underlying)
Footnotes (2)
- [F1]The options were granted by LogicBio Therapeutics, Inc. (the "Company") pursuant to its 2018 Equity Incentive Plan.
- [F2]The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Company on each vesting date.